SE412236B - Forfarande for framstellning av nya penicillinforeningar - Google Patents

Forfarande for framstellning av nya penicillinforeningar

Info

Publication number
SE412236B
SE412236B SE7213592A SE1359272A SE412236B SE 412236 B SE412236 B SE 412236B SE 7213592 A SE7213592 A SE 7213592A SE 1359272 A SE1359272 A SE 1359272A SE 412236 B SE412236 B SE 412236B
Authority
SE
Sweden
Prior art keywords
parts
weight
yield
oxo
imidazolidin
Prior art date
Application number
SE7213592A
Other languages
English (en)
Swedish (sv)
Inventor
H-B Konig
W Schrock
K G Metzger
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of SE412236B publication Critical patent/SE412236B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D239/08—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms directly attached in position 2
    • C07D239/10—Oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/06—Anabolic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom
    • C07D233/38—One oxygen atom with acyl radicals or hetero atoms directly attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/34—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/10—Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
SE7213592A 1971-10-23 1972-10-20 Forfarande for framstellning av nya penicillinforeningar SE412236B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2152967A DE2152967C3 (de) 1971-10-23 1971-10-23 Acylureidopenicilline

Publications (1)

Publication Number Publication Date
SE412236B true SE412236B (sv) 1980-02-25

Family

ID=5823251

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7213592A SE412236B (sv) 1971-10-23 1972-10-20 Forfarande for framstellning av nya penicillinforeningar

Country Status (31)

Country Link
JP (2) JPS55391B2 (cs)
AR (1) AR195805A1 (cs)
AT (1) AT320152B (cs)
BE (1) BE790440A (cs)
BG (2) BG20813A3 (cs)
CA (1) CA1019323A (cs)
CH (1) CH579089A5 (cs)
CS (1) CS188883B2 (cs)
CY (1) CY947A (cs)
DD (1) DD106044B3 (cs)
DE (1) DE2152967C3 (cs)
DK (1) DK134992C (cs)
EG (1) EG10826A (cs)
ES (1) ES407851A1 (cs)
FI (1) FI56839C (cs)
FR (1) FR2157908B1 (cs)
GB (1) GB1392849A (cs)
HK (1) HK18578A (cs)
HU (1) HU167986B (cs)
IE (1) IE37123B1 (cs)
IL (1) IL40628A (cs)
KE (1) KE2824A (cs)
LU (1) LU66332A1 (cs)
NO (1) NO143909C (cs)
PH (1) PH9893A (cs)
PL (2) PL93574B1 (cs)
RO (2) RO60670A (cs)
SE (1) SE412236B (cs)
SU (1) SU527139A3 (cs)
YU (1) YU264072A (cs)
ZA (1) ZA727473B (cs)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3972870A (en) * 1971-10-23 1976-08-03 Bayer Aktiengesellschaft Penicillins
US3983105A (en) * 1971-10-23 1976-09-28 Bayer Aktiengesellschaft Penicillins
US4009272A (en) * 1971-10-23 1977-02-22 Bayer Aktiengesellschaft Penicillins
US3978056A (en) * 1971-10-23 1976-08-31 Bayer Aktiengesellschaft Penicillins
US3974141A (en) * 1971-10-23 1976-08-10 Bayer Aktiengesellschaft Penicillins
NL175419C (nl) * 1971-10-23 1984-11-01 Bayer Ag Werkwijze ter bereiding of vervaardiging van antibiotisch werkzame farmaceutische preparaten, alsmede werkwijze ter bereiding van antibiotisch werkzame alfa-gesubstitueerde 6-(alfa-(3-acylureido)acetylamino) penicillanzuurderivaten.
US3972869A (en) * 1971-10-23 1976-08-03 Bayer Aktiengesellschaft Penicillins
US3974142A (en) * 1971-10-23 1976-08-10 Bayer Aktiengesellschaft Penicillins
DE2258973A1 (de) * 1972-12-01 1974-06-06 Bayer Ag Penicilline, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
JPS587637B2 (ja) * 1973-12-27 1983-02-10 住友化学工業株式会社 シンキペニシリンノ セイホウ
DE2407715C2 (de) * 1974-02-18 1982-12-02 Bayer Ag, 5090 Leverkusen Cephalosporine, Verfahren zu ihrer Herstellung sowie Arzneimittel
IL47168A (en) * 1974-05-09 1979-07-25 Toyama Chemical Co Ltd Mono or dioxo piperazino(thio)carbonylamino derivatives ofpenicillins and cephalosporins and process for producing the same
DE2525541C2 (de) * 1975-06-07 1984-01-12 Bayer Ag, 5090 Leverkusen β-Lactam-Antibiotica, Verfahren zu ihrer Herstellung sowie sie enthaltende Arzneimittel
DE2810083A1 (de) 1978-03-08 1979-09-20 Bayer Ag Beta-lactam-verbindungen
GB0420722D0 (en) * 2004-09-17 2004-10-20 Addex Pharmaceuticals Sa Novel allosteric modulators
EP1780213A1 (en) * 2005-10-27 2007-05-02 3M Innovative Properties Company Silicon-urea-azolides, their preparation and use in the preparation of silicones with isocyanate terminal groups
AR059898A1 (es) 2006-03-15 2008-05-07 Janssen Pharmaceutica Nv Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2
TW200845978A (en) 2007-03-07 2008-12-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
TW200900065A (en) 2007-03-07 2009-01-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
US9114138B2 (en) 2007-09-14 2015-08-25 Janssen Pharmaceuticals, Inc. 1′,3′-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2H,1′H-[1,4′] bipyridinyl-2′-ones
ES2409215T3 (es) 2007-09-14 2013-06-25 Janssen Pharmaceuticals, Inc. 4-fenil-1H-piridin-2-onas 1-3-disustituidas
EP2200985B1 (en) 2007-09-14 2011-07-13 Ortho-McNeil-Janssen Pharmaceuticals, Inc. 1,3-disubstituted 4-(aryl-x-phenyl)-1h-pyridin-2-ones
WO2009062676A2 (en) 2007-11-14 2009-05-22 Ortho-Mcneil-Janssen Pharmaceuticals, Inc. Imidazo[1,2-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
BRPI0918055A2 (pt) 2008-09-02 2015-12-01 Addex Pharmaceuticals Sa derivados de 3-azabiciclo[3,1,0]hexila como moduladores de receptores metabotrópicos de glutamato.
ES2466341T3 (es) 2008-10-16 2014-06-10 Janssen Pharmaceuticals, Inc. Derivados de indol y benzomorfolina como moduladores de receptores de glutamato metabotrópicos
WO2010060589A1 (en) 2008-11-28 2010-06-03 Ortho-Mcneil-Janssen Pharmaceuticals, Inc. Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors
KR101753826B1 (ko) 2009-05-12 2017-07-04 얀센 파마슈티칼즈, 인코포레이티드 1,２,４―트리아졸로［４,３―ａ］피리딘 유도체 및 신경정신 질환의 치료 또는 예방을 위한 이들의 용도
SG176018A1 (en) 2009-05-12 2011-12-29 Janssen Pharmaceuticals Inc 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
MY153913A (en) 2009-05-12 2015-04-15 Janssen Pharmaceuticals Inc 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
WO2010142241A1 (en) * 2009-06-10 2010-12-16 Techfields Biochem Co., Ltd. High penetration compositions or prodrugs of antimicrobials and antimicrobial-related compounds
WO2012062751A1 (en) 2010-11-08 2012-05-18 Janssen Pharmaceuticals, Inc. 1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
CN103298810B (zh) 2010-11-08 2016-03-16 杨森制药公司 1,2,4-三唑并[4,3-a]吡啶衍生物及其作为MGLUR2受体的正变构调节剂的用途
AU2011328203B2 (en) 2010-11-08 2015-03-19 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
JO3368B1 (ar) 2013-06-04 2019-03-13 Janssen Pharmaceutica Nv مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
JO3367B1 (ar) 2013-09-06 2019-03-13 Janssen Pharmaceutica Nv مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
PT3096790T (pt) 2014-01-21 2019-10-15 Janssen Pharmaceutica Nv Combinações compreendendo moduladores alostéricos positivos ou agonistas ortostéricos do recetor glutamatérgico metabotrópico do subtipo 2 e seu uso
SMT202100103T1 (it) 2014-01-21 2021-03-15 Janssen Pharmaceutica Nv Combinazione comprendente modulatori allosterici postivi del recettore glutammatergico metabotropico sottotipo 2 e loro utilizzo

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1770620A1 (de) * 1968-06-12 1971-11-11 Bayer Ag Neue Penicilline

Also Published As

Publication number Publication date
BE790440A (cs) 1973-04-24
DK134992C (da) 1977-07-18
PL93574B1 (cs) 1977-06-30
JPS4849910A (cs) 1973-07-14
FR2157908B1 (cs) 1976-03-19
DE2152967B2 (de) 1981-02-19
IE37123L (en) 1973-04-23
BG21609A3 (bg) 1976-07-20
DE2152967C3 (de) 1981-11-19
GB1392849A (en) 1975-04-30
FR2157908A1 (cs) 1973-06-08
PH9893A (en) 1976-06-08
IL40628A (en) 1976-08-31
HK18578A (en) 1978-04-14
ES407851A1 (es) 1975-10-01
AR195805A1 (es) 1973-11-09
CA1019323A (en) 1977-10-18
LU66332A1 (cs) 1973-01-23
IL40628A0 (en) 1972-12-29
SU527139A3 (ru) 1976-08-30
BG20813A3 (bg) 1975-12-20
AU4806472A (en) 1974-04-26
EG10826A (en) 1976-12-31
FI56839B (fi) 1979-12-31
HU167986B (cs) 1976-02-28
NO143909C (no) 1981-05-06
CH579089A5 (cs) 1976-08-31
CY947A (en) 1978-06-23
JPS57843B2 (cs) 1982-01-08
DD106044A5 (cs) 1974-05-20
PL89056B1 (cs) 1976-10-30
NO143909B (no) 1981-01-26
DK134992B (da) 1977-02-21
RO63066A (fr) 1978-06-15
AT320152B (de) 1975-01-27
ZA727473B (en) 1973-07-25
IE37123B1 (en) 1977-05-11
RO60670A (cs) 1976-10-15
KE2824A (en) 1978-04-07
DE2152967A1 (de) 1973-05-03
JPS4849787A (cs) 1973-07-13
FI56839C (fi) 1980-04-10
JPS55391B2 (cs) 1980-01-08
DD106044B3 (de) 1990-07-18
YU264072A (en) 1982-06-18
CS188883B2 (en) 1979-03-30

Similar Documents

Publication Publication Date Title
SE412236B (sv) Forfarande for framstellning av nya penicillinforeningar
US4416880A (en) β-Lactam antibiotics and compositions containing the same
SE438855B (sv) 3-hydroxikrotonsyraderivat till anvendning sasom mellanprodukt vid syntesen av 3-cefemforeningar
SE446536B (sv) Forfarande for framstellning av omettade derivat av 7-acylamido-3-cefem-4-karboxylsyra
US4016282A (en) Ureidoacetamido-penicillins
US3996217A (en) 3-Triazolylthio derivatives of ureido cephalosporins
JPS6114151B2 (cs)
US4009272A (en) Penicillins
US3974142A (en) Penicillins
US4223037A (en) β-Lactam antibiotics and their use
US3983105A (en) Penicillins
US3939149A (en) Ureidoacetamido-penicillins
US3975375A (en) Penicillins
US4110535A (en) 3-oxopyridazinylthiomethyl derivatives of ureidocephalosporins
US4039532A (en) 4-(Tetrazol-5-yl)-Δ3 -cephem compounds
US4127716A (en) 3-heterothiomethyl ureido cephalosporins
US3933795A (en) Ureidoacetamido-penicillins
US3972870A (en) Penicillins
US4045436A (en) 4-(Tetrazol-5-yl)-Δ3 -cephem compounds
US4088816A (en) 3-Heterothio substituted 7-(ureido-heteroacetyl) cephalosporins
US3974141A (en) Penicillins
US3980792A (en) Ureidoacetamido-penicillins
US4045437A (en) 4-(Tetrazol-5-yl)-Δ3 -cephem compounds
CA1050010A (en) Process for preparing-3-methyl-4-(5-tetrazolyl)-a3-cephem compounds
US4029653A (en) 7-Methoxy 7-alpha-ureidothienylacetamidocephalosporins